Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹9,279 Cr
up ₹235 Cr vs Jun 2026
- Stocks held
- 35
- unchanged
- Top 10 weight
- 57.3%
- of the portfolio in its ten largest
- Cash & debt
- 2.7%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 12
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In July 2026 it disclosed 35 stocks worth ₹9,279 Cr, up ₹235 Cr from Jun 2026. Its largest positions were Sun Pharmaceutical Industries Limited (13.3%), Lupin Limited (7.2%), Divi's Laboratories Limited (6.5%); the ten largest together made up 57.3% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 75.1% of its equity. Cash and debt stood at 2.7%. Compared with Jun 2026 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
77%
Top-10 weight is higher than 77% of peers
Breadth
26%
Holds more stocks than 26% of peers
Cash
38%
Holds more cash than 38% of peers
Holdings in July 2026
Download CSVEvery line the fund disclosed, with the change against Jun 2026. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.31%
- Δ weight
- up 0.53 pts
- Value
- ₹1,235 Cr
- Δ value
- up ₹79.4 Cr
- Status
- Added
- Weight
- 7.25%
- Δ weight
- down 0.20 pts
- Value
- ₹672 Cr
- Δ value
- down ₹1.1 Cr
- Status
- Held
- Weight
- 6.52%
- Δ weight
- up 1.06 pts
- Value
- ₹605 Cr
- Δ value
- up ₹111 Cr
- Status
- Added
- Weight
- 6.03%
- Δ weight
- down 0.12 pts
- Value
- ₹559 Cr
- Δ value
- up ₹3 Cr
- Status
- Added
- Weight
- 5.30%
- Δ weight
- up 0.03 pts
- Value
- ₹492 Cr
- Δ value
- up ₹15.1 Cr
- Status
- Added
- Weight
- 5.01%
- Δ weight
- down 1.67 pts
- Value
- ₹465 Cr
- Δ value
- down ₹139 Cr
- Status
- Trimmed
- Weight
- 3.74%
- Δ weight
- down 0.29 pts
- Value
- ₹347 Cr
- Δ value
- down ₹17.5 Cr
- Status
- Trimmed
- Weight
- 3.62%
- Δ weight
- up 0.13 pts
- Value
- ₹336 Cr
- Δ value
- up ₹20.7 Cr
- Status
- Added
- Weight
- 3.41%
- Δ weight
- down 0.05 pts
- Value
- ₹317 Cr
- Δ value
- up ₹3.9 Cr
- Status
- Added
- Weight
- 3.15%
- Δ weight
- down 0.17 pts
- Value
- ₹292 Cr
- Δ value
- down ₹8.2 Cr
- Status
- Trimmed
- Weight
- 2.69%
- Δ weight
- down 0.48 pts
- Value
- ₹250 Cr
- Δ value
- down ₹37.5 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 2.68%
- Δ weight
- up 0.29 pts
- Value
- ₹249 Cr
- Δ value
- up ₹33 Cr
- Status
- Added
- Weight
- 2.66%
- Δ weight
- up 0.18 pts
- Value
- ₹247 Cr
- Δ value
- up ₹22.9 Cr
- Status
- Added
- Weight
- 2.57%
- Δ weight
- up <0.01 pts
- Value
- ₹239 Cr
- Δ value
- up ₹6.4 Cr
- Status
- Added
- Weight
- 2.51%
- Δ weight
- down 0.15 pts
- Value
- ₹233 Cr
- Δ value
- down ₹7.3 Cr
- Status
- Trimmed
- Weight
- 2.42%
- Δ weight
- down 0.38 pts
- Value
- ₹225 Cr
- Δ value
- down ₹28.4 Cr
- Status
- Trimmed
- Weight
- 2.24%
- Δ weight
- up 0.15 pts
- Value
- ₹208 Cr
- Δ value
- up ₹18.8 Cr
- Status
- Added
- Weight
- 2.16%
- Δ weight
- down 0.05 pts
- Value
- ₹200 Cr
- Δ value
- up ₹63 L
- Status
- Held
- Weight
- 2.09%
- Δ weight
- up 1.07 pts
- Value
- ₹194 Cr
- Δ value
- up ₹102 Cr
- Status
- Added
- Weight
- 2.05%
- Δ weight
- up 0.20 pts
- Value
- ₹191 Cr
- Δ value
- up ₹23 Cr
- Status
- Added
- Weight
- 2.01%
- Δ weight
- up 0.01 pts
- Value
- ₹186 Cr
- Δ value
- up ₹5.9 Cr
- Status
- Added
- Weight
- 1.80%
- Δ weight
- up 0.01 pts
- Value
- ₹167 Cr
- Δ value
- up ₹4.7 Cr
- Status
- Added
- Weight
- 1.65%
- Δ weight
- up 0.09 pts
- Value
- ₹154 Cr
- Δ value
- up ₹12.2 Cr
- Status
- Added
- Weight
- 1.58%
- Δ weight
- up 0.06 pts
- Value
- ₹146 Cr
- Δ value
- up ₹9.3 Cr
- Status
- Added
- Weight
- 1.54%
- Δ weight
- down 0.21 pts
- Value
- ₹143 Cr
- Δ value
- down ₹15.7 Cr
- Status
- Trimmed
- Weight
- 1.46%
- Δ weight
- down 0.25 pts
- Value
- ₹135 Cr
- Δ value
- down ₹18.8 Cr
- Status
- Trimmed
- Weight
- 1.37%
- Δ weight
- down 0.05 pts
- Value
- ₹127 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 1.07%
- Δ weight
- up 0.21 pts
- Value
- ₹99.6 Cr
- Δ value
- up ₹21.2 Cr
- Status
- Added
- Weight
- 1.06%
- Δ weight
- down 0.02 pts
- Value
- ₹98.5 Cr
- Δ value
- up ₹30 L
- Status
- Held
- Weight
- 1.06%
- Δ weight
- down 0.12 pts
- Value
- ₹98.2 Cr
- Δ value
- down ₹8.1 Cr
- Status
- Trimmed
- Weight
- 1.00%
- Δ weight
- down 0.03 pts
- Value
- ₹92.5 Cr
- Δ value
- down ₹29 L
- Status
- Held
- Weight
- 0.92%
- Δ weight
- up 0.02 pts
- Value
- ₹85.7 Cr
- Δ value
- up ₹4.1 Cr
- Status
- Added
- Weight
- 0.92%
- Δ weight
- up 0.24 pts
- Value
- ₹85.3 Cr
- Δ value
- up ₹23.8 Cr
- Status
- Added
- Weight
- 0.55%
- Δ weight
- down 0.02 pts
- Value
- ₹50.7 Cr
- Δ value
- down ₹79 L
- Status
- Trimmed
- Weight
- 0.43%
- Δ weight
- down 0.05 pts
- Value
- ₹40.3 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 0.17%
- Δ weight
- up 0.01 pts
- Value
- ₹15.9 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
What changed, Jun 2026 to Jul 2026
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Divi's Laboratories Limitedup ₹111 Cr (+1.06% pts)
- Piramal Pharma Limitedup ₹102 Cr (+1.07% pts)
- Sun Pharmaceutical Industries Limitedup ₹79.4 Cr (+0.53% pts)
- Biocon Limitedup ₹23.8 Cr (+0.24% pts)
- Dr. Lal Path Labs Limitedup ₹23 Cr (+0.20% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jun 2026, the weight rose most in Pharmaceuticals & Biotechnology (+1.4 pts), and fell most in Healthcare Services (−0.8 pts) and Retailing (−0.5 pts).
- Pharmaceuticals & Biotechnology73.7% → 75.1%+1.4 pts
- Healthcare Services22.5% → 21.7%−0.8 pts
- Retailing3.3% → 2.8%−0.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jul 2023 | Jul 2025 | Jan 2026 | Apr 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.3% | 75.5% | 74.6% | 74.1% | 73.7% | 75.1% |
| Healthcare Services | 17.8% | 20.0% | 21.2% | 21.6% | 22.5% | 21.7% |
| Retailing | 3.5% | 3.9% | 3.7% | 3.8% | 3.3% | 2.8% |
| Pharmaceuticals | 1.1% | 0.7% | 0.5% | 0.5% | 0.5% | 0.4% |
Allocation in Jul 2026change vs Jun 2026
- Pharmaceuticals & Biotechnology (24)75.1%▲ 1.4 pts
- Healthcare Services (9)21.7%▼ 0.8 pts
- Retailing (1)2.8%▼ 0.5 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jul 2026
2.7%
▲ 0.3 pts vs Jun 2026
- Cash alone
- 2.7%
- cash and net receivables
- A year earlier
- 0.5%
- Jul 2025 · now ▲ 2.1 pts
- Last 12 months
- 0.3% – 2.7%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.